Overseas Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OVERSEAS, and what generic and branded alternatives to OVERSEAS drugs are available?
OVERSEAS has one approved drug.
Drugs and US Patents for Overseas
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Overseas | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 212688-001 | Jun 11, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Overseas | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 212688-002 | May 5, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.